The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program

J. Timothy Baldwin, Harvey S. Borovetz, Brian W. Duncan, Mark J. Gartner, Robert K. Jarvik, William Weiss, Tracey R. Hoke

Research output: Contribution to journalReview article

141 Citations (Scopus)

Abstract

Options for the circulatory support of pediatric patients under the age of 5 years are currently limited to short-term extracorporeal devices, the use of which is often complicated by infection, bleeding, and thromboembolism. Recognizing this void, the National Heart, Lung, and Blood Institute solicited proposals for the development of novel circulatory support systems for infants and children from 2 to 25 kg with congenital or acquired cardiovascular disease. Five contracts were awarded to develop a family of devices that includes (1) an implantable mixed-flow ventricular assist device designed specifically for patients up to 2 years of age, (2) another mixed-flow ventricular assist device that can be implanted intravascularly or extravascularly depending on patient size, (3) compact integrated pediatric cardiopulmonary assist systems, (4) apically implanted axial-flow ventricular assist devices, and (5) pulsatile-flow ventricular assist devices. The common objective for these devices is to reliably provide circulatory support for infants and children while minimizing risks related to infection, bleeding, and thromboembolism. The devices are expected to be ready for clinical studies at the conclusion of the awards in 2009.

Original languageEnglish (US)
Pages (from-to)147-155
Number of pages9
JournalCirculation
Volume113
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Heart-Assist Devices
Pediatrics
Equipment and Supplies
Thromboembolism
Hemorrhage
Pulsatile Flow
Contracts
Cardiovascular System
Infection
Cardiovascular Diseases

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Baldwin, J. T., Borovetz, H. S., Duncan, B. W., Gartner, M. J., Jarvik, R. K., Weiss, W., & Hoke, T. R. (2006). The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation, 113(1), 147-155. https://doi.org/10.1161/CIRCULATIONAHA.105.571422
Baldwin, J. Timothy ; Borovetz, Harvey S. ; Duncan, Brian W. ; Gartner, Mark J. ; Jarvik, Robert K. ; Weiss, William ; Hoke, Tracey R. / The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. In: Circulation. 2006 ; Vol. 113, No. 1. pp. 147-155.
@article{abcc6e0dfe7b4045a514557327943621,
title = "The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program",
abstract = "Options for the circulatory support of pediatric patients under the age of 5 years are currently limited to short-term extracorporeal devices, the use of which is often complicated by infection, bleeding, and thromboembolism. Recognizing this void, the National Heart, Lung, and Blood Institute solicited proposals for the development of novel circulatory support systems for infants and children from 2 to 25 kg with congenital or acquired cardiovascular disease. Five contracts were awarded to develop a family of devices that includes (1) an implantable mixed-flow ventricular assist device designed specifically for patients up to 2 years of age, (2) another mixed-flow ventricular assist device that can be implanted intravascularly or extravascularly depending on patient size, (3) compact integrated pediatric cardiopulmonary assist systems, (4) apically implanted axial-flow ventricular assist devices, and (5) pulsatile-flow ventricular assist devices. The common objective for these devices is to reliably provide circulatory support for infants and children while minimizing risks related to infection, bleeding, and thromboembolism. The devices are expected to be ready for clinical studies at the conclusion of the awards in 2009.",
author = "Baldwin, {J. Timothy} and Borovetz, {Harvey S.} and Duncan, {Brian W.} and Gartner, {Mark J.} and Jarvik, {Robert K.} and William Weiss and Hoke, {Tracey R.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1161/CIRCULATIONAHA.105.571422",
language = "English (US)",
volume = "113",
pages = "147--155",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Baldwin, JT, Borovetz, HS, Duncan, BW, Gartner, MJ, Jarvik, RK, Weiss, W & Hoke, TR 2006, 'The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program', Circulation, vol. 113, no. 1, pp. 147-155. https://doi.org/10.1161/CIRCULATIONAHA.105.571422

The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. / Baldwin, J. Timothy; Borovetz, Harvey S.; Duncan, Brian W.; Gartner, Mark J.; Jarvik, Robert K.; Weiss, William; Hoke, Tracey R.

In: Circulation, Vol. 113, No. 1, 01.01.2006, p. 147-155.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program

AU - Baldwin, J. Timothy

AU - Borovetz, Harvey S.

AU - Duncan, Brian W.

AU - Gartner, Mark J.

AU - Jarvik, Robert K.

AU - Weiss, William

AU - Hoke, Tracey R.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Options for the circulatory support of pediatric patients under the age of 5 years are currently limited to short-term extracorporeal devices, the use of which is often complicated by infection, bleeding, and thromboembolism. Recognizing this void, the National Heart, Lung, and Blood Institute solicited proposals for the development of novel circulatory support systems for infants and children from 2 to 25 kg with congenital or acquired cardiovascular disease. Five contracts were awarded to develop a family of devices that includes (1) an implantable mixed-flow ventricular assist device designed specifically for patients up to 2 years of age, (2) another mixed-flow ventricular assist device that can be implanted intravascularly or extravascularly depending on patient size, (3) compact integrated pediatric cardiopulmonary assist systems, (4) apically implanted axial-flow ventricular assist devices, and (5) pulsatile-flow ventricular assist devices. The common objective for these devices is to reliably provide circulatory support for infants and children while minimizing risks related to infection, bleeding, and thromboembolism. The devices are expected to be ready for clinical studies at the conclusion of the awards in 2009.

AB - Options for the circulatory support of pediatric patients under the age of 5 years are currently limited to short-term extracorporeal devices, the use of which is often complicated by infection, bleeding, and thromboembolism. Recognizing this void, the National Heart, Lung, and Blood Institute solicited proposals for the development of novel circulatory support systems for infants and children from 2 to 25 kg with congenital or acquired cardiovascular disease. Five contracts were awarded to develop a family of devices that includes (1) an implantable mixed-flow ventricular assist device designed specifically for patients up to 2 years of age, (2) another mixed-flow ventricular assist device that can be implanted intravascularly or extravascularly depending on patient size, (3) compact integrated pediatric cardiopulmonary assist systems, (4) apically implanted axial-flow ventricular assist devices, and (5) pulsatile-flow ventricular assist devices. The common objective for these devices is to reliably provide circulatory support for infants and children while minimizing risks related to infection, bleeding, and thromboembolism. The devices are expected to be ready for clinical studies at the conclusion of the awards in 2009.

UR - http://www.scopus.com/inward/record.url?scp=33644854087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644854087&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.105.571422

DO - 10.1161/CIRCULATIONAHA.105.571422

M3 - Review article

C2 - 16391168

AN - SCOPUS:33644854087

VL - 113

SP - 147

EP - 155

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -